Recipient Organization
OREGON STATE UNIVERSITY
(N/A)
CORVALLIS,OR 97331
Performing Department
Animal and Rangeland Sciences
Non Technical Summary
Uterine infections during the period after calving, or the postpartum period, are a significant problem to dairy producers. Dairy cows are particularly susceptible to develop uterine infections because of conditions associated with housing and production. Bacterial infections, such as endometritis, metritis and pyometra, occurring within 28 days postpartum affect 10 to 50% of cows annually. Fertility is reduced in cows with uterine infections because of abnormal reproductive cycles, lower conception rates (20% lower than healthy cows), and longer days open (an average of 30 days longer than healthy cows). The cost of days open beyond 100 days has been estimated to be as much as $5.40/day for the dairy cow. Depending on the uterine infection incidence one uses to calculate cost to Oregon dairy producers on a state-wide basis, income loss is estimated to range between $2 million to 10.1 million annually. During pregnancy, the uterus is a sterile environment, but during calving and the early postpartum period, bacteria from the cow's environment can colonize the uterus, causing infection. It is known that uterine susceptibility to bacterial infection is higher when the ovarian hormone progesterone is high and is lower when the ovarian hormone estrogen and the uterine hormone prostaglandin F2a (PGF) are high. These findings, though important, have not aided in the development of new methods of prevention and treatment of uterine infections. Significant research effort has been directed towards studying the pathogenic microorganisms that cause uterine infections. However, despite this research, preventative practices and new treatment strategies have not been developed, and the incidence of uterine infection has not changed significantly in cattle over the previous 30 years. New knowledge in this area is a necessary first step towards development of new and practical methods for preventing uterine infections and novel therapeutic regimes not requiring antibiotics for treatment. Our laboratory demonstrated that a single injection of Lutalyse (the pharmaceutical product of PGF) increased the number of circulating neutrophils within one hour after injection and for several hours thereafter. In a second experiment, Lutalyse injections on either Days 0-1 and 14 or Days 14 and 28 postpartum increased neutrophils and decreased total bacteria in the uterus and decreased days open and services per conception. The greatest effect was observed in cows injected on Days 0-1 and 14. Endogenous PGF would be high around parturition (Day 0) but low by Day 14. The Day 14 Lutalyse injection may function to maintain high plasma PGF in the early postpartum period most susceptible to uterine infections. Therefore, our hypothesis is a single injection of Lutalyse on Day 14 postpartum will increase uterine neutrophils and decrease uterine bacterial load thereby decreasing days open and services per conception. Expected outcomes and impacts include a change in knowledge, where the results of this basic research will be published in a scientific journal, and a potential change in conditions in better and less expensive animal health.
Animal Health Component
(N/A)
Research Effort Categories
Basic
(N/A)
Applied
(N/A)
Developmental
(N/A)
Goals / Objectives
Maintenance of uterine health during the period after calving, or the postpartum period, is a significant challenge for dairy producers. Fertility is poorer in cows with uterine infections and in Oregon this reduced fertility can contribute to an income loss estimated to reach as high as $10 million annually. Uterine resistance to bacterial infection seems to be greater when the uterine hormone prostaglandin F2a (PGF) is high. Our laboratory demonstrated that a single injection of Lutalyse (the pharmaceutical product of PGF) increased the number of circulating neutrophils within one hour after injection and for several hours thereafter. In a second experiment, Lutalyse injections on either Days 0-1 and 14 or Days 14 and 28 postpartum increased neutrophils and decreased total bacteria in the uterus and decreased days open and services per conception. The greatest effect was observed in cows injected on Days 0-1 and 14. Endogenous PGF would be high around parturition (Day 0) but low by Day 14. The Day 14 Lutalyse injection may function to maintain high plasma PGF in the early postpartum period most susceptible to uterine infections. A single Lutalyse injection on Day 14 may be the simplest and most efficacious preemptive strategy for dairymen to counter uterine infections and improve uterine health and fertility. Therefore, the objective of this proposal is to evaluate the effects of a single Lutalyse injection administered on Day 14 postpartum on uterine bacterial and neutrophil populations and numbers of days open and services per conception in postpartum dairy cows. Expected outputs: Activities - conducting and analyzing experiments in the research project and teaching and mentoring graduate students; Events - presenting the results of the research at scientific societal conferences and training graduate students in this research; Products - graduating students with master's or doctoral degrees.
Project Methods
Eighty postpartum cows at the OSU Dairy Center will be randomly assigned to two treatments (forty cows per treatment) and injected with either saline (5 ml; im) or Lutalyse (25 mg/5 ml; im) on Day 14 postpartum (where Day 0 = day of calving). On the day of the injection, the cow's uterus will be sampled for uterine bacterial load using a double guarded swab (Time 0). Twenty-four h after the first swab, a second uterine swab will be collected (Time 24). To provide an assessment of the uterine neutrophil population, a guarded CytoBrush will be passed into the uterus immediately following the uterine swabbing at Times 0 and 24. The CytoBrush will be rolled onto a microscope slide to create a cell smear and neutrophils will be counted. Blood samples (10 ml) will be drawn by coccygeal venipuncture at Times 0 and 24 to assay plasma progesterone concentrations. Serial dilutions will be made from the original uterine sample and 100 ul will be plated onto each side of a Blood Agar/MacConkey's Agar bacteriological culture biplate. Colony counts on the blood agar side provide the total number of pathogenic bacteria and counts from the MacConkey's agar side provide the number of E.coli. All cows on experiment will be evaluated daily for evidence of uterine infections, e.g., vaginal discharge, fever, etc. Herd records will be evaluated in a timely fashion and data pertaining to days open and services per conception will be collected for analysis. Differences due to treatment in the total numbers of bacteria, E. coli and neutrophils and plasma progesterone will be analyzed by repeated measures analysis of variance (ANOVA). If significant effects are observed in the ANOVA, differences between means will be evaluated by Fisher's least significant differences procedures. Observational data, e.g., number of cows observed with uterine infections, will be analyzed for differences using Chi-square procedures. Differences due to treatment in the numbers of days open and services per conception will be evaluated using the pooled t-test. Lutalyse treatment should increase uterine neutrophils and decrease uterine bacterial load thereby improving uterine health and decreasing days open and services per conception. Significant savings can be realized by dairy producers implementing such a protocol because of the reduced expense associated with fewer days open and reduced labor and semen costs associated with fewer services per conception. A functional pre-emptive strategy would also decrease antibiotic use, further reducing drug costs. Efforts will include adding this information into material used for formal classroom and laboratory instruction and outreach. Lutalyse is commonly used in dairy operations to synchronize estrous cycles for artificial insemination and a single dose is under $3.00. Therefore, this protocol can be easily implemented with relatively little cost. It is anticipated the results of this research will be published in a format accessible to dairy producers for information. The success and merit of the study will be evaluated by tracking the number of times the publication reporting this research is cited in the scientific literature.